Deciphering von Hippel-Lindau (VHL/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations.
The von Hippel-Lindau (VHL) syndrome is a pleomorphic familial disease characterized by the development of highly vascularized tumors, such as hemangioblastomas of the central nervous system, pheochromocytomas, renal cell carcinomas, cysts and neuroendocrine tumors of the pancreas. Up to 75% of VHL...
Saved in:
| Main Authors: | H-C Jennifer Shen, Asha Adem, Kris Ylaya, Arianne Wilson, Mei He, Dominique Lorang, Stephen M Hewitt, Klaus Pechhold, David M Harlan, Irina A Lubensky, Laura S Schmidt, W Marston Linehan, Steven K Libutti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2009-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0004897&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors.
by: Lee E Moore, et al.
Published: (2011-10-01) -
Pathogenicity of germline VHL variants is associated with renal cell carcinoma size in von Hippel-Lindau disease
by: Gustavo H. Mori, et al.
Published: (2025-02-01) -
Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification.
by: Qiliang Cai, et al.
Published: (2010-03-01) -
Von Hippel-Lindau (VHL) Protein Antagonist VH298 Improves Wound Healing in Streptozotocin-Induced Hyperglycaemic Rats by Activating Hypoxia-Inducible Factor- (HIF-) 1 Signalling
by: Shuo Qiu, et al.
Published: (2019-01-01) -
Molecular dynamics reveal potential effects of novel VHL variants on VHL-Elongin C binding in ccRCC patients from Eastern India
by: Srilagna Chatterjee, et al.
Published: (2025-04-01)